CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Lags Revenue Estimates

EarningsNegative
AI Analysis

Summary

Syndax Pharmaceuticals reported Q2 2026 results with a net loss and revenue that fell short of estimates. The company's financial performance lagged market expectations in the quarter.

Importance:4/10
Sentiment:
-0.40
earningsQ2_2026revenue_missloss
Related Companies

Read the original article

Published by yahoo_finance on August 4, 2026 9:15 PM

Read Original